
BioGaia Investor Relations Material
Latest events

Q1 2025
BioGaia
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioGaia
Access all reports
BioGaia AB develops and markets a wide range of probiotic products with documented health benefits. The company is focused on human health, animal health and the environment, and creates new benefits through the development of novel target groups and or applications. The company's current product portfolio includes Dysbiosis Treatment, Concept 2, Gastrointestinal Fortifier, Protectis, Nestum, Synbiome Defense, and Vi-sualize. Its products are used in various applications such as food supplement industry, animal health sector and human health sector.
Key slides for BioGaia
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
BIOG
Country
🇸🇪 Sweden